<DOC>
	<DOCNO>NCT01987310</DOCNO>
	<brief_summary>The aim current study evaluate association fatty liver severity endothelial function Non-Alcoholic Fatty Liver Disease ( NAFLD ) patient find impact statin treatment compare usual care life style modification endothelial function , liver steatosis fibrosis .</brief_summary>
	<brief_title>Assessment Endothelial Function Patients With Non Alcoholic Fatty Liver Disease Impact Statin Treatment</brief_title>
	<detailed_description>The study cohort include 150 patient fatty liver per ultrasound histology . The patient divide randomly one three arm : follow group , lifestyle modification group , statins therapy ( Atorvastatin 20mg/d 6 month ) . screening , 6 month ( end treatment ) , 12 month patient undergo : 1. complete physical examination 2. blood pressure measurement 3. assessment height weight , body mass index waist circumference 4. blood sample complete blood count , fast plasma glucose , fast plasma insulin , lipid profile , liver enzymes , albumin , bilirubin , Prothrombin time ( PT INR ) , Hemoglobin A1c , ferritin , adiponectin , C-reactive protein , Tumor necrosis factor alpha , Lipoprotein-phospholipase A2 , Apolipoproteins B100 , A1 , C3 , C4 , ceruloplasmin 5 . Liver elastography sonographic liver fat quantification 6 . Brachial artery flow-mediated dilatation ( FMD ) measurement</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>subject willing comply study requirement sign informed consent form fatty liver per abdominal ultrasound liver biopsy alcohol drinking &gt; 140g/week presence hepatitis B C HIV know liver disease fatty liver usage drug know cause liver steatosis subject know allergy hypersensitivity statins subject know cardiovascular/cerebrovascular disease subject know dyslipidemia require drug treatment subject diabetes mellitus history drug alcohol abuse refusal sig inform consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>non alcoholic fatty liver disease</keyword>
	<keyword>endothelial function</keyword>
	<keyword>liver steatosis</keyword>
	<keyword>liver fibrosis</keyword>
	<keyword>statin treatment</keyword>
</DOC>